Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.

Area of Science:

• Immunogenetics
• Rheumatology
• Neuroimmunology

Background:

• Autoimmune diseases arise from complex genetic and environmental factors.
• Interferon regulatory factor-5 (IRF5) is a key regulator in innate and adaptive immunity.
• Genetic variations in IRF5 have been implicated in various autoimmune conditions.

Purpose of the Study:

• To conduct a meta-analysis investigating the association between specific interferon regulatory factor-5 (IRF5) single nucleotide polymorphisms (SNPs) and susceptibility to multiple autoimmune diseases.
• To consolidate evidence from existing studies to determine the role of IRF5 polymorphisms in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), juvenile idiopathic arthritis (JIA), multiple sclerosis (MS), and systemic sclerosis (SSc).

Main Methods:

• A comprehensive meta-analysis was performed using data from 28 studies with 74 comparisons, sourced from the Medline citation index.
• Studies included rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), juvenile idiopathic arthritis (JIA), multiple sclerosis (MS), and systemic sclerosis (SSc).
• Statistical analysis focused on identifying significant associations between specific IRF5 SNPs (rs2004640, rs2280714, rs10954213, rs2070197, exon 6 insertion) and disease risk.

Main Results:

• The IRF5 SNP rs2004640 showed significant association with SLE, MS, and SSc, but not JIA or RA.
• SNP rs2280714 was significantly associated with SLE, MS, and SSc, but not RA.
• SNP rs10954213 was linked to the pathogenesis of SLE, RA, MS, and SSc. rs2070197 and the exon 6 insertion were significantly associated with SLE.
• Haplotypes involving rs2004640T and rs2280714T increased SLE risk but not RA risk.

Conclusions:

• This meta-analysis confirms that IRF5 polymorphisms confer susceptibility to systemic lupus erythematosus (SLE), multiple sclerosis (MS), and systemic sclerosis (SSc).
• Specific IRF5 SNPs and haplotypes are associated with increased risk for certain autoimmune diseases.
• Further large-scale, global studies are required to fully elucidate the correlations between IRF5 polymorphisms and autoimmune disease susceptibility.